TREATMENTMAP Trademark

Trademark Overview


On Tuesday, April 29, 2014, a trademark application was filed for TREATMENTMAP with the United States Patent and Trademark Office. The USPTO has given the TREATMENTMAP trademark a serial number of 86266118. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, November 30, 2018. This trademark is owned by Molecular Health GmbH. The TREATMENTMAP trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

(Based on 44(d) Priority Application) (Based on Intent to Use) Medical and clinical laboratory apparatus and instruments for next generation sequencing of genomic DNA for the purpose of cancer diagnostic molecular testing, in particular, cancer genomic testing and testing of genomic changes, and related automated decision support tools for diagnostic and therapeutic application, namely, computer application software and hardware for use with the laboratory apparatus and instruments

(Based on 44(d) Priority Application) (Based on Intent to Use) Data collection for scientific research, analytical and clinical purposes, in particular the collection and systematic sorting of patient's specific molecular, genomic and/or clinical data, in particular relating to genomic changes, in particular relating to cancer genomic changes; providing medical research information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; scientific clinical studies in the field of medicine; data collection for scientific research and analytical purposes, in particular the collection of mathematical and statistical data, clinical data, patient's genomic data and data of clinical studies relating to patient's clinical responses to drug treatments and treatment regimes; compiling data for research and analytical purposes in the field of medical science and diagnostics, in particular compiling patient spe...

(Based on 44(d) Priority Application) (Based on Intent to Use) Providing online databases featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options, in particular in the field of clinical diagnostics and therapy, in particular in the field of cancer diagnostics and cancer therapy; medical consulting services with respect to the treatment and diagnosis of individuals with cancer in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; medical consulting services in the fields of patient treatments and treatment protocols for cancer
treatmentmap

General Information


Serial Number86266118
Word MarkTREATMENTMAP
Filing DateTuesday, April 29, 2014
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, November 30, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and Services(Based on 44(d) Priority Application) (Based on Intent to Use) Medical and clinical laboratory apparatus and instruments for next generation sequencing of genomic DNA for the purpose of cancer diagnostic molecular testing, in particular, cancer genomic testing and testing of genomic changes, and related automated decision support tools for diagnostic and therapeutic application, namely, computer application software and hardware for use with the laboratory apparatus and instruments
Goods and Services(Based on 44(d) Priority Application) (Based on Intent to Use) Data collection for scientific research, analytical and clinical purposes, in particular the collection and systematic sorting of patient's specific molecular, genomic and/or clinical data, in particular relating to genomic changes, in particular relating to cancer genomic changes; providing medical research information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; scientific clinical studies in the field of medicine; data collection for scientific research and analytical purposes, in particular the collection of mathematical and statistical data, clinical data, patient's genomic data and data of clinical studies relating to patient's clinical responses to drug treatments and treatment regimes; compiling data for research and analytical purposes in the field of medical science and diagnostics, in particular compiling patient specific molecular and genomic data, in particular cancer genomic data; scientific, technical and research services, namely, scientific, technical and medical research for medical purposes in the field of medical diagnostic and optimization of treatment regimes; providing medical and scientific research information and scientific research consulting in the fields of pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and interpretation of analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of data obtained from cancer patients, specifically patient's genomic changes that contribute to a patient's unique cancer disease; providing an online database featuring medical, pharmaceutical, biological and genomic scientific research information for medical and diagnostic purposes; providing an online searchable database in the fields of medical, pharmaceutical, biological, clinical and genomic scientific research information for scientific research, analytical and clinical purposes; providing an online searchable database featuring scientific research in the fields of cancer medicine, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis; design and development of computer software in the fields of biology, medicine, and bioinformatics; design and development of computer software for integration of patient's specific data, molecular test results, clinical studies and scientific results; providing online non-downloadable computer software for use by healthcare professionals for medical diagnostic and treatment, in particular in the field of cancer diagnosis and therapy; design and development of databases featuring biomarker data; providing an online searchable database featuring scientific research information in the fields of analysis and optimization of protocols used in cancer treatment, for medical, diagnostic and clinical use; Software as a Service (SAAS) services featuring software for providing information for patient's treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, in particular designing and conducting scientific research drug safety and dosage assessment and drug compatibility studies in the field of cancer therapy for others; providing pharmaceutical scientific and medical research information, in particular research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individual patients; consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals; providing an on-line, non-downloadable computer platform for purposes of storing and providing information about patient's individual cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice
Goods and Services(Based on 44(d) Priority Application) (Based on Intent to Use) Providing online databases featuring medical information and diagnostic, prophylactic and therapeutic properties of pharmaceuticals, and genomic information as it relates to medical diagnosis and treatment; pharmaceutical consulting services in pharmaceuticals and genetics in relation to patient medical treatment options, in particular in the field of clinical diagnostics and therapy, in particular in the field of cancer diagnostics and cancer therapy; medical consulting services with respect to the treatment and diagnosis of individuals with cancer in the fields of clinical pharmacology and the analysis of dose-effect relationships for treatment purposes; medical consulting services in the fields of patient treatments and treatment protocols for cancer
Pseudo MarkTREATMENT MAP

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateMonday, February 23, 2015
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 13, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 13, 2014
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMolecular Health GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHeidelberg 69115
DE

Trademark Events


Event DateEvent Description
Friday, November 30, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, November 30, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, April 30, 2018NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, April 30, 2018INQUIRY TO SUSPENSION E-MAILED
Monday, April 30, 2018SUSPENSION INQUIRY WRITTEN
Thursday, April 26, 2018LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, October 23, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, October 23, 2017LETTER OF SUSPENSION E-MAILED
Monday, October 23, 2017SUSPENSION LETTER WRITTEN
Thursday, October 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, October 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 4, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, April 6, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, April 6, 2017LETTER OF SUSPENSION E-MAILED
Thursday, April 6, 2017SUSPENSION LETTER WRITTEN
Thursday, April 6, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 6, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, September 30, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, September 30, 2016INQUIRY TO SUSPENSION E-MAILED
Friday, September 30, 2016SUSPENSION INQUIRY WRITTEN
Saturday, September 17, 2016LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, March 16, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 16, 2016LETTER OF SUSPENSION E-MAILED
Wednesday, March 16, 2016SUSPENSION LETTER WRITTEN
Thursday, March 10, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 10, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 3, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, October 6, 2015NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, October 6, 2015INQUIRY TO SUSPENSION E-MAILED
Tuesday, October 6, 2015SUSPENSION INQUIRY WRITTEN
Wednesday, September 30, 2015LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, March 16, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 16, 2015LETTER OF SUSPENSION E-MAILED
Monday, March 16, 2015SUSPENSION LETTER WRITTEN
Monday, February 23, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 23, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 16, 2015ASSIGNED TO LIE
Thursday, February 12, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 9, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 9, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 13, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 13, 2014NON-FINAL ACTION E-MAILED
Wednesday, August 13, 2014NON-FINAL ACTION WRITTEN
Monday, August 11, 2014ASSIGNED TO EXAMINER
Wednesday, May 14, 2014NOTICE OF PSEUDO MARK E-MAILED
Tuesday, May 13, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 2, 2014NEW APPLICATION ENTERED IN TRAM